Natera, Inc. (NTRA)
NASDAQ: NTRA · Real-Time Price · USD
237.12
+0.63 (0.27%)
At close: Nov 26, 2025, 4:00 PM EST
237.00
-0.12 (-0.05%)
After-hours: Nov 26, 2025, 6:26 PM EST
Natera Revenue
Natera had revenue of $592.18M in the quarter ending September 30, 2025, with 34.66% growth. This brings the company's revenue in the last twelve months to $2.12B, up 38.17% year-over-year. In the year 2024, Natera had annual revenue of $1.70B with 56.75% growth.
Revenue (ttm)
$2.12B
Revenue Growth
+38.17%
P/S Ratio
15.12
Revenue / Employee
$477,374
Employees
4,434
Market Cap
32.73B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 1.70B | 614.34M | 56.75% |
| Dec 31, 2023 | 1.08B | 262.35M | 31.99% |
| Dec 31, 2022 | 820.22M | 194.74M | 31.13% |
| Dec 31, 2021 | 625.49M | 234.48M | 59.97% |
| Dec 31, 2020 | 391.01M | 88.68M | 29.33% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 435.16B |
| Johnson & Johnson | 92.15B |
| Merck & Co. | 64.24B |
| AbbVie | 59.64B |
| Eli Lilly and Company | 59.42B |
| AstraZeneca | 58.13B |
| Novartis AG | 56.37B |
| Novo Nordisk | 49.58B |
NTRA News
- 6 days ago - Natera, Inc. (NTRA) Presents at 7th Annual Wolfe Research Healthcare Conference Transcript - Seeking Alpha
- 8 days ago - Natera, Inc. (NTRA) Presents at Jefferies London Healthcare Conference 2025 Transcript - Seeking Alpha
- 8 days ago - Employees Volunteer Over 1,500 Hours During Natera's Annual Volunteer Month - Business Wire
- 15 days ago - Natera Integrates with Flatiron Health's OncoEMR® Platform - Business Wire
- 20 days ago - Natera, Inc. (NTRA) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 20 days ago - Natera Reports Third Quarter 2025 Financial Results - Business Wire
- 27 days ago - Natera Announces Expansion to 20 Genes for its Fetal Focus™ Single-Gene NIPT - Business Wire
- 4 weeks ago - Natera to Report its Third Quarter Results on November 6, 2025 - Business Wire